Related Experiment Video
Updated: May 14, 2026

Surgical Technique for the Implantation of Tissue Engineered Vascular Grafts and Subsequent In Vivo Monitoring
Published on: April 3, 2015
Vascular graft infections
Barbara Hasse1, Lars Husmann, Annelies Zinkernagel
1Division of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Switzerland. barbara.hasse@usz.ch
Abstract:
Vascular procedures are rarely complicated by infection, but if prosthetic vascular graft infection (PVGI) occurs, morbidity and mortality are high. Several patient-related, surgery-related and postoperative risk factors are reported, but they are not well validated. PVGI is due to bacterial colonisation of the wound and the underlying prosthetic graft, generally as a result of direct contamination during the operative procedure, mainly from the patient's skin or adjacent bowel. There is no consensus on diagnostic criteria or on the best management of PVGI. On the basis of reported clinical studies and our own experience, we advocate a surgical approach combining repeated radical local debridement, with graft preservation whenever possible or partial excision of the infected graft, depending on its condition, plus simultaneous negative-pressure wound therapy (NPWT). In addition, antimicrobial therapy is recommended, but there is no consensus on which classes of agent are adequate for the treatment of PVGI and whether certain infections may be treated by means of NPWT alone. Since staphylococci and Gram-negative rods are likely to be isolated, empirical treatment might include a penicillinase-resistant beta-lactam or a glycopeptide, plus an aminoglycoside, the latter for Gram-negative coverage and synergistic treatment of Gram-positive cocci. Additionally, empirical treatment might include rifampicin since it penetrates well into biofilms.
Insights
Prosthetic vascular graft infection (PVGI) has high morbidity and mortality. A combined approach of debridement, graft preservation or partial excision, and negative-pressure wound therapy (NPWT) is recommended for managing PVGI.
Area of Science:
- Vascular Surgery
- Infectious Diseases
- Wound Management
Background:
- Prosthetic vascular graft infection (PVGI) is a rare but serious complication with high morbidity and mortality.
- Risk factors for PVGI are not well-validated, and the etiology involves bacterial colonization from operative contamination.
- There is a lack of consensus on diagnostic criteria and optimal management strategies for PVGI.
Purpose of the Study:
- To advocate for a comprehensive surgical approach to managing prosthetic vascular graft infections.
- To discuss the role of negative-pressure wound therapy (NPWT) and antimicrobial strategies in PVGI treatment.
- To provide recommendations for empirical antimicrobial therapy based on likely pathogens.
Main Methods:
- Advocacy for a surgical approach combining repeated radical local debridement.
- Graft preservation or partial excision based on graft condition.
- Simultaneous application of negative-pressure wound therapy (NPWT) and antimicrobial therapy.
Main Results:
- The proposed management strategy aims to reduce morbidity and mortality associated with PVGI.
- Negative-pressure wound therapy (NPWT) may play a role in treating certain PVGI cases.
- Empirical antimicrobial therapy should cover common pathogens like staphylococci and Gram-negative rods.
Conclusions:
- A combined surgical approach with debridement, potential graft preservation/excision, and NPWT is recommended for PVGI.
- Antimicrobial therapy is crucial, with empirical choices including penicillinase-resistant beta-lactams/glycopeptides and aminoglycosides.
- Rifampicin is suggested for empirical treatment due to its biofilm penetration properties.
Related Concept Videos
Hemodialysis I: Introduction
Aneurysm III: Interprofessional Care
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis

